Profile
Hedi Ben Brahim currently works at One Biosciences SAS, as Chief Executive Officer from 2023, Institut Mérieux SA, as Operational Director- Immunotherapy Division from 2018, Transgene, Inc., as Director, Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd., as Director, and GeNeuro SA (Switzerland), as Independent Director from 2020.
Mr. Brahim also formerly worked at Vallourec Drilling Products France SAS, as Chief Executive Officer-Europe Africa Division, Advanced BioScience Laboratories, Inc., as Chairman, Fabentech SAS, as Chairman-Supervisory Board, Transgene SA, as Director in 2023, Vallourec SA, as Vice President-Corporate Planning, VAM USA LLC, as General Manager-Production, and France Ministry of Labor, Social Affairs, Family & Solidarity, as Head-Health Products.
Mr. Brahim received his undergraduate degree from École Nationale Supérieure des Mines de Paris.
Hedi Brahim active positions
| Companies | Position | Start |
|---|---|---|
| GENEURO SA | Director/Board Member | 2020-05-26 |
Transgene, Inc.
Transgene, Inc. The company is based in Dover, DE. The company develops therapeutic vaccines and oncolytic viruses designed to stimulate and harness the immune system to target and destroy cancer cells. Its core technologies include the myvac® platform for individualized neoantigen vaccines and the invir.io® platform for multifunctional oncolytic viruses, which modulate the tumor microenvironment and directly attack tumors. Transgene employs advanced genetic engineering, viral vector molecular design, and artificial intelligence to tailor therapies to patients’ tumor-specific mutations. Transgene, Inc. was founded in 1982. | Director/Board Member | - |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member | - |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Corporate Officer/Principal | 2018-08-31 |
One Biosciences SAS
One Biosciences SAS Provides single-cell technology research and development services | Chief Executive Officer | 2023-09-06 |
Former positions of Hedi Brahim
| Companies | Position | End |
|---|---|---|
| TRANSGENE | Chief Executive Officer | 2023-05-31 |
Advanced BioScience Laboratories, Inc.
Advanced BioScience Laboratories, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization dedicated to advancing therapeutics, vaccines & biological products | Chairman | 2022-12-31 |
Fabentech SAS
Fabentech SAS Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Chairman | 2020-12-31 |
France Ministry of Labor, Social Affairs, Family & Solidarity
France Ministry of Labor, Social Affairs, Family & Solidarity Oversees social welfare policy | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Hedi Brahim
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Vallourec SA
Vallourec SA SteelNon-Energy Minerals Manufactures and distributes steel and alloy tubing used by the automobile, oil and gas refining, petrochemical and other industries | Non-Energy Minerals |
École Nationale Supérieure des Mines de Paris
École Nationale Supérieure des Mines de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced BioScience Laboratories, Inc.
Advanced BioScience Laboratories, Inc. BiotechnologyHealth Technology Operates as a contract development and manufacturing organization dedicated to advancing therapeutics, vaccines & biological products | Health Technology |
VAM USA LLC
VAM USA LLC Wholesale DistributorsDistribution Services Supplies threaded connections for oil and gas industry | Distribution Services |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Transgene, Inc.
Transgene, Inc. The company is based in Dover, DE. The company develops therapeutic vaccines and oncolytic viruses designed to stimulate and harness the immune system to target and destroy cancer cells. Its core technologies include the myvac® platform for individualized neoantigen vaccines and the invir.io® platform for multifunctional oncolytic viruses, which modulate the tumor microenvironment and directly attack tumors. Transgene employs advanced genetic engineering, viral vector molecular design, and artificial intelligence to tailor therapies to patients’ tumor-specific mutations. Transgene, Inc. was founded in 1982. | |
Fabentech SAS
Fabentech SAS Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | |
Vallourec Drilling Products France SAS
Vallourec Drilling Products France SAS Manufactures and supplies drilling products | |
France Ministry of Labor, Social Affairs, Family & Solidarity
France Ministry of Labor, Social Affairs, Family & Solidarity Oversees social welfare policy | |
GeNeuro SA (Switzerland)
GeNeuro SA (Switzerland) Engages in the research and development of pharmaceutical products to treat neurological diseases | |
One Biosciences SAS
One Biosciences SAS Provides single-cell technology research and development services |
- Stock Market
- Insiders
- Hedi Brahim
















